Schrodinger, Inc. - 10-Q Filing

Schrodinger, Inc. reports Q3 2026 financial results with revenue split between Software Products and Services and Drug Discovery segments.

SEC EDGAR ·

Tickers: $SDGR

Read the full article at SEC EDGAR

More Regulatory news